Perrigo Indication-Specific Analgesics Slated For Mid-2001 Launch
This article was originally published in The Tan Sheet
Executive Summary
Perrigo plans to launch a Women's Menstrual Relief analgesic in April, comparable to McNeil Consumer Healthcare's Women's Tylenol, which debuted in October.
You may also be interested in...
Perrigo Boosts R&D Spending, Focuses On Quality Control
Perrigo plans to increase R&D spending in the second half of FY 2001 pending a favorable FDA follow-up manufacturing audit of the firm's Allegan, Mich. facility, President & CEO David Gibbons told analysts during a conference call Jan. 23.
Perrigo Boosts R&D Spending, Focuses On Quality Control
Perrigo plans to increase R&D spending in the second half of FY 2001 pending a favorable FDA follow-up manufacturing audit of the firm's Allegan, Mich. facility, President & CEO David Gibbons told analysts during a conference call Jan. 23.
Perrigo Boosts R&D Spending, Focuses On Quality Control
Perrigo plans to increase R&D spending in the second half of FY 2001 pending a favorable FDA follow-up manufacturing audit of the firm's Allegan, Mich. facility, President & CEO David Gibbons told analysts during a conference call Jan. 23.